Institutions / Versant Venture Management, LLC
Versant Venture Management, LLC
CIK 1560009 · Institution · as of Dec 31, 2025
Portfolio value
$151.06M
Positions
7
As of
Dec 31, 2025
Top holdings
Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Monte Rosa Therapeutics, Inc. | $68.72M | 45.5% |
| LENZ Therapeutics, Inc. | $42.51M | 28.1% |
| Jade Biosciences, Inc. | $23.54M | 15.6% |
| CRISPR Therapeutics AG | $7.80M | 5.2% |
| Contineum Therapeutics, Inc. | $6.20M | 4.1% |
| Skye Bioscience, Inc.SKYE | $1.51M | 1.0% |
| Tempest Therapeutics, Inc. | $774.2K | 0.5% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.